VBData
动脉网
VBData is a conference and forum platform in China's healthcare and biotech space, co-organized with venture capital firms and industry media. Per BlueRun Ventures materials, it partnered with the firm to host a May 2024 forum on peptide drugs and industrial-chain innovation in Beijing, alongside VB100, Artery Network, Eggshell Research Institute, and Artery Orange . The "VB" prefix and its collaboration with VB100 suggest it sits within the same media and events ecosystem as the latter. elsewhere's corpus does not cover VBData's founding, ownership structure, or activities beyond these 2024 co-hosted events.
AI-generated — may contain errors, please verify.
Coverage
The Trillion-Yuan Blueprint for Peptide Drugs: From Diabetes Medication to Weight-Loss Wonder | BlueRun Ventures Biotech Forum Recap
From Pharmaceuticals to Consumer Goods: A Wave of Value Creation
BlueRun Ventures Portfolio Companies Named to 2024 Future Healthcare 100 List
Continuously searching for next-generation biotech companies that align with industry logic
With a Market Worth Hundreds of Billions, When Will Peptide Drugs Become the Next Blockbuster? | BlueRun Ventures × VBData Forum Now Open for Registration
Where Does the Hot Peptide Market Go From Here?
Multiple BlueRun Ventures portfolio companies named to 2023 Future Healthcare 100 list
Standing by founders from 0 to 1 to redefine the future.
BlueRun Ventures and Portfolio Companies Win Nearly 60 Awards from 36Kr, ChinaVenture, Rongzhong, TMTpost, VBData, and More | H1 Highlights
Deep commitment to early-stage investing, with a belief in technology as a driver of transformation.
